Onconeuronal antibodies may act as markers for the specific tumors, e.g., anti-Yo for breast or reproductive system tumors, anti-Hu for small-cell lung cancer, anti-Ri for breast or lung or anti-Ma2 for testicle malignancy. This evidence concerns the gene CDR2 and reproductive system neoplasm.